Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Xtant Medical Holdings Inc (XTNT)

Xtant Medical Holdings Inc (XTNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 73,406
  • Shares Outstanding, K 101,981
  • Annual Sales, $ 55,260 K
  • Annual Income, $ -4,850 K
  • 60-Month Beta 1.02
  • Price/Sales 1.29
  • Price/Cash Flow N/A
  • Price/Book 2.17
Trade XTNT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings -0.02 on 08/04/22
  • Next Earnings Date 11/11/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4900 +46.90%
on 09/01/22
0.7200 -0.03%
on 09/30/22
+0.1872 (+35.15%)
since 08/30/22
3-Month
0.4291 +67.75%
on 08/22/22
0.7200 -0.03%
on 09/30/22
+0.2003 (+38.56%)
since 06/30/22
52-Week
0.4291 +67.75%
on 08/22/22
1.2700 -43.32%
on 11/02/21
-0.3902 (-35.15%)
since 09/30/21

Most Recent Stories

More News
Xtant Medical Announces Second Quarter 2022 Financial Results

BELGRADE, Mont., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022

BELGRADE, Mont., July 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical Announces First Quarter 2022 Financial Results

BELGRADE, Mont., May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical Appoints Scott Neils as Chief Financial Officer

BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022

BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022

BELGRADE, Mont., March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical Announces Fourth Quarter and Full Year 2021 Financial Results

BELGRADE, Mont., March 08, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical to Issue Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022

BELGRADE, Mont., March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical Appoints Scott Neils Interim Chief Financial Officer

BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)
Xtant Medical Announces Third Quarter 2021 Financial Results

BELGRADE, Mont., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on...

XTNT : 0.7198 (+2.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery...

See More

Key Turning Points

3rd Resistance Point 0.7599
2nd Resistance Point 0.7399
1st Resistance Point 0.7299
Last Price 0.7198
1st Support Level 0.6999
2nd Support Level 0.6799
3rd Support Level 0.6699

See More

52-Week High 1.2700
Fibonacci 61.8% 0.9488
Fibonacci 50% 0.8496
Fibonacci 38.2% 0.7503
Last Price 0.7198
52-Week Low 0.4291

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar